Literature DB >> 225270

Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.

A A Gershon, S P Steinberg.   

Abstract

Humoral and cell-mediated immune responses to varicella-zoster (V-Z) virus were assessed in patients during and after V-Z infections. Ongoing V-Z infections was associated with minimal cellular immunity but not necessarily with poor humoral immunity. Recovery from V-Z infection was associated with a vigorous cellular immune response. Cell-mediated immunity to V-Z virus was demonstrable for years after varicella, but responses were lower in immunocompromised patients than in normal individuals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225270      PMCID: PMC414434          DOI: 10.1128/iai.25.1.170-174.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  The long term effects of radiation of T and B lymphocytes in the peripheral blood after regional irradiation.

Authors:  R T Hoppe; Z Y Fuks; S Strober; H S Kaplan
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

2.  Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

3.  Cellular immunity and herpesvirus infections in cardiac-transplant patients.

Authors:  K H Rand; L E Rasmussen; R B Pollard; A Arvin; T C Merigan
Journal:  N Engl J Med       Date:  1977-06-16       Impact factor: 91.245

4.  Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles).

Authors:  A S Russell; R A Maini; M Bailey; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

Review 5.  Viral infections in man associated with acquired immunological deficiency states.

Authors:  T C Merigan; D A Stevens
Journal:  Fed Proc       Date:  1971 Nov-Dec

6.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

7.  Cell-mediated immunity to varicella-zoster virus: in vitro lymphocyte responses.

Authors:  G W Jordan; T C Merigan
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

8.  Varicella in children with cancer: Seventy-seven cases.

Authors:  S Feldman; W T Hughes; C B Daniel
Journal:  Pediatrics       Date:  1975-09       Impact factor: 7.124

9.  Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin's disease.

Authors:  J C Ruckdeschel; S C Schimpff; A C Smyth; M R Mardiney
Journal:  Am J Med       Date:  1977-01       Impact factor: 4.965

10.  Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes.

Authors:  A A Gershon; S Steinberg; M Smith
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

View more
  11 in total

1.  Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.

Authors:  Cindy Gutzeit; Martin J Raftery; Matthias Peiser; Karsten B Tischer; Martina Ulrich; Melanie Eberhardt; Eggert Stockfleth; Thomas Giese; Andreas Sauerbrei; Craig T Morita; Günther Schönrich
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

Review 2.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

3.  Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccination.

Authors:  Kareem Jamani; Judy MacDonald; Martin Lavoie; Tyler S Williamson; Christopher B Brown; Ahsan Chaudhry; Victor H Jimenez-Zepeda; Peter Duggan; Jason Tay; Douglas Stewart; Andrew Daly; Jan Storek
Journal:  Blood Adv       Date:  2016-11-30

Review 4.  Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia.

Authors:  D Gilden
Journal:  J Intern Med       Date:  2011-02-23       Impact factor: 8.989

5.  Inhibition of varicella-zoster virus in vitro by human peripheral blood mononuclear cells.

Authors:  G P Rabalais; F E Berkowitz; A R Hayward; M J Levin
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

6.  High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis.

Authors:  K Nagasawa; Y Yamauchi; Y Tada; T Kusaba; Y Niho; H Yoshikawa
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

Review 7.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

Review 8.  Varicella-zoster.

Authors:  Don Gilden; Maria A Nagel; Randall J Cohrs
Journal:  Handb Clin Neurol       Date:  2014

9.  Inactivation of varicella zoster virus in vitro: effect of leukocytes and specific antibody.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

10.  Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes.

Authors:  Afsar Sayeeda; Hussain Al Arfaj; Najma Khalil; A S Al Arfaj
Journal:  Autoimmune Dis       Date:  2010-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.